Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors
Robust and accurate quantification of recombinant adeno-associated virus (rAAV) vectors’ infectivity is essential for pre-clinical and clinical development of AAV gene therapy programs. The industry standard method for rAAV titration is the 50% tissue culture infectious dose (TCID50) assay using HeL...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2025-06-01
|
| Edice: | Molecular Therapy: Methods & Clinical Development |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2329050125000877 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
